ArQule Message Board - Msg: 7141347

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (305)	1/6/1999 11:18:00 PM
From: Miljenko Zuanic	Read Replies (1) of 399

Thanks John. New pharma partner will be nice news, but there are other things for which I care more. Which will make me satisfied and bring confidence. What is going on with new CEO? What and how He/She will execute (new) strategy and business plan? What are status of the current collaboration? Are there any significant progress: partner(s) satisfaction with collaborations?, did any partner chose candidate from ARQL libraries and is ready for IND?, progress in proprietary programs?,.... Good compound is worth as much as good target, but one have to make and identify such candidate. Hope, we may have little update on this issue. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next